A pregnant woman with placenta percreta diagnosed by MRI presenting with vaginal bleeding at a facility lacking capability for management—what should the physician do?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta Percreta with Vaginal Bleeding at an Inadequate Facility

Refer the patient immediately with direct notification to the receiving department, ensuring stabilization measures are in place during transfer. 1

Immediate Physician Responsibilities

The American College of Obstetricians and Gynecologists explicitly states that when placenta accreta spectrum (including percreta) is encountered at a facility lacking expertise and the patient is stable after delivery of the fetus, the patient should be transferred to a facility that can perform the necessary level of care. 1 This principle applies even more urgently when the patient presents before delivery with active bleeding.

Why Option A (Refer with Notifying Department) is Correct

  • Direct physician-to-physician communication with the receiving tertiary center is mandatory to ensure appropriate resources are mobilized before the patient arrives. 1
  • The receiving facility needs advance notice to assemble the multidisciplinary team including maternal-fetal medicine subspecialists, gynecologic oncologists or experienced pelvic surgeons, urologists, interventional radiologists, obstetric anesthesiologists, and blood bank personnel capable of massive transfusion protocols. 1
  • Placenta percreta requires delivery at a level III or IV maternal care center with considerable experience, as outcomes are significantly improved with coordinated multidisciplinary care. 1

Pre-Transfer Stabilization Protocol

Before transport, the referring physician must:

  • Establish large-bore intravenous access (two sites minimum) for rapid fluid and blood product administration. 2, 3
  • Activate massive transfusion protocol and begin transfusion if significant bleeding is present, without waiting for laboratory results. 2, 3
  • Obtain baseline laboratory studies including complete blood count, type and crossmatch for at least 4-6 units of packed red blood cells, coagulation panel, platelet count, and fibrinogen level. 2
  • Maintain maternal temperature above 36°C during stabilization, as clotting factors function poorly at lower temperatures. 2, 3
  • Consider tranexamic acid administration (1 gram IV over 10 minutes) to reduce blood loss during transfer. 2, 3

Critical Communication Elements

When notifying the receiving department, provide:

  • Gestational age and confirmation of placenta percreta diagnosis by MRI 1
  • Current hemodynamic status and volume of vaginal bleeding 1
  • Prior cesarean deliveries or uterine surgeries (risk increases 7-fold after one cesarean, up to 56-fold after three cesareans) 4
  • Blood products administered and current laboratory values 1
  • Estimated time of arrival 1

Why Other Options Are Inadequate

Option B (Refer upon patient's request) is dangerous and inappropriate because it delays life-saving transfer and places the burden of decision-making on a patient who may not understand the severity of her condition. 1

Option C (Discharge with referral form) is medically negligent for a patient with active vaginal bleeding and placenta percreta, as she requires continuous monitoring and immediate access to resuscitation during transport. 1, 2

Option D (Discharge and tell her to go to tertiary hospital) is equally negligent because it provides no medical oversight during transfer and no coordination with the receiving facility. 1

Common Pitfalls to Avoid

  • Do not attempt cesarean delivery at an inadequate facility even if bleeding worsens—temporary measures including abdominal packing and tranexamic acid infusion should be used while arranging emergent transfer. 2
  • Do not delay transfer waiting for "optimal" stabilization—placenta percreta can deteriorate rapidly, and transfer should occur as soon as basic resuscitation is initiated. 1
  • Do not assume the patient can self-transport—medical transport with monitoring and resuscitation capability is essential. 1, 2
  • Failure to notify the receiving center in advance can result in catastrophic delays in assembling the necessary surgical team and blood products. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Placental Abruption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intraoperative Management of Revealed Placental Abruption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the typical placental description in a case of placenta percreta in an adult female with a history of previous uterine surgery or placenta previa?
What is the best management approach for a primigravid (first-time pregnant) patient with placenta percreta?
What is the recommended management for a pregnant woman with suspected placenta percreta?
What are the key findings and management strategies for a woman of childbearing age with a history of uterine surgery or previous placental abnormalities diagnosed with placenta percreta?
What makes placenta accreta more serious than placenta previa and why is delivery at 34-35 weeks recommended?
What is the recommended management for a patient presenting with acute uncomplicated diverticulitis (no perforation, abscess, obstruction, peritonitis, or systemic instability), and how should the approach differ for older or immunocompromised patients, those with significant comorbidities such as uncontrolled diabetes or chronic steroid use, or those exhibiting systemic signs like high fever, tachycardia, or marked leukocytosis?
How should I manage an otherwise healthy adult with acute uncomplicated diverticulitis (left lower quadrant (LLQ) pain, fever <38.5 °C, no peritoneal signs, and no abscess or perforation on computed tomography (CT)), and what changes for complicated diverticulitis (abscess ≥3 cm, perforation, peritonitis, or fistula)?
How does the Rai staging (sliding‑scale) guide observation versus treatment decisions in chronic lymphocytic leukemia?
In adult patients with Stevens‑Johnson syndrome or toxic epidermal necrolysis, does cyclosporine alone provide different outcomes compared with cyclosporine combined with systemic corticosteroids?
What are the benefits of using keto‑analogues in adult patients with chronic kidney disease stage IIIb who are on a very‑low‑protein diet?
In an adult with Stevens‑Johnson syndrome/toxic epidermal necrolysis already receiving cyclosporine, should systemic corticosteroids be added?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.